Figure CC

See text for description.

In 2018, the proportion of isolates with elevated azithromycin minimum inhibitory concentrations (MICs) (≥2.0 μg/mL) and elevated ceftriaxone MICS (≥0.125 μg/mL) was higher in isolates from MSM than from MSW. For azithromycin, 8.2% of isolates from MSM had elevated MICs compared to 2.4% in MSW. For ceftriaxone, the proportion was slightly higher at 0.22% in MSM compared to 0.16% in MSW.